NCT01487915View on ClinicalTrials.gov

Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2015

Conditions
Advanced Urothelial Carcinoma
Interventions
DRUG

GCb

Gemcitabine 1000 mg/㎡ D1, D8 plus Carboplatin AUC=4.5 D1 every 3 weeks

DRUG

GemOx

Gemcitabine 1000 mg/㎡ D1 plus Oxaliplatin 100 mg/㎡ D1 every 2 weeks

Trial Locations (5)

700-712

RECRUITING

Keimyeong University Dongsan Medical Center, Daegu

301-721

RECRUITING

Chungnam University Hospital, Daejeon

136-705

RECRUITING

Korea University Anam Hospital, Seoul

138-736

RECRUITING

Asan Medical Center, Seoul

156-755

NOT_YET_RECRUITING

Chung Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER